QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 26, 2003, 23(34):10953-10962

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Quirk, J. C. Articles by Nisenbaum, E. S. Search for Related Content PubMed PubMed Citation Articles by Quirk, J. C. Articles by Nisenbaum, E. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOTHIAZIDE

 Previous Article  |  Next Article 

Behavioral/Systems/Cognitive
Multiple Molecular Determinants for Allosteric Modulation of Alternatively Spliced AMPA Receptors

Jennifer C. Quirk and Eric S. Nisenbaum

Neuroscience Division, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285

Positive allosteric regulation of glutamate AMPA receptors involves conformational changes that can attenuate receptor desensitization and enhance ion flux through the channel pore. Many allosteric modulators (e.g., cyclothiazide and aniracetam) preferentially affect the flip (i) or flop (o) alternatively spliced isoform of AMPA receptors, implicating residues in the flip-flop domain as critical determinants of splice variant sensitivity. Indeed, previous mutational analyses have demonstrated that the differential sensitivity to cyclothiazide and aniracetam depends on a single amino acid, Ser (flip) and Asn (flop), suggesting that this residue may be solely responsible for differences in modulation of AMPA receptor isoforms. The present studies tested this hypothesis by investigating the molecular determinants of modulation of AMPA receptor splice variants by a structurally distinct compound, LY404187, which displays strikingly different and opposing kinetics of allosteric regulation characterized by a time-dependent enhancement in potentiation of homomeric GluR1-GluR4i and a time-dependent reduction in potentiation of GluR1-GluR4o. Site-directed mutagenesis of residues in the flip-flop domain of GluR2 revealed that, although exchange of Asn775 for Ser in GluR2o was sufficient to confer the GluR2i phenotype of potentiation, the corresponding mutation, Ser775Asn, in GluR2i did not impart the GluR2o response. In fact, the GluR2o kinetics of modulation depended on a novel set of substitutions in GluR2i, including Thr765Asn, Pro766Ala, and Val779Leu in combination with Ser775Asn. Collectively, these results show that, unlike cyclothiazide and aniracetam, the residues that confer splice variant differences in modulation by LY404187 are not identical and indicate that allosteric regulation of AMPA receptors can arise from multiple molecular determinants.

Key words: aniracetam; biarylpropylsulfonamide; cyclothiazide; flip; flop; alternative splicing

---

Received July 30, 2003; revised September 12, 2003; accepted October 1, 2003.

This article has been cited by other articles:

				S. K. Coleman, T. Moykkynen, C. Cai, L. von Ossowski, E. Kuismanen, E. R. Korpi, and K. Keinanen Isoform-Specific Early Trafficking of AMPA Receptor Flip and Flop Variants J. Neurosci., October 25, 2006; 26(43): 11220 - 11229. [Abstract] [Full Text] [PDF]

				R. Jin, S. Clark, A. M. Weeks, J. T. Dudman, E. Gouaux, and K. M. Partin Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors J. Neurosci., September 28, 2005; 25(39): 9027 - 9036. [Abstract] [Full Text] [PDF]

				A. Frandsen, D. S. Pickering, B. Vestergaard, C. Kasper, B. B. Nielsen, J. R. Greenwood, G. Campiani, C. Fattorusso, M. Gajhede, A. Schousboe, et al. Tyr702 Is an Important Determinant of Agonist Binding and Domain Closure of the Ligand-Binding Core of GluR2 Mol. Pharmacol., March 1, 2005; 67(3): 703 - 713. [Abstract] [Full Text] [PDF]

				J. C. Quirk, E. R. Siuda, and E. S. Nisenbaum Molecular Determinants Responsible for Differences in Desensitization Kinetics of AMPA Receptor Splice Variants J. Neurosci., December 15, 2004; 24(50): 11416 - 11420. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help